BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 38613348)

  • 21. New insights into the Hippo/YAP pathway in idiopathic pulmonary fibrosis.
    Sun M; Sun Y; Feng Z; Kang X; Yang W; Wang Y; Luo Y
    Pharmacol Res; 2021 Jul; 169():105635. PubMed ID: 33930530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. WW Domain-Containing Proteins YAP and TAZ in the Hippo Pathway as Key Regulators in Stemness Maintenance, Tissue Homeostasis, and Tumorigenesis.
    Chen YA; Lu CY; Cheng TY; Pan SH; Chen HF; Chang NS
    Front Oncol; 2019; 9():60. PubMed ID: 30805310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Hippo signalling pathway and its implications in human health and diseases.
    Fu M; Hu Y; Lan T; Guan KL; Luo T; Luo M
    Signal Transduct Target Ther; 2022 Nov; 7(1):376. PubMed ID: 36347846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stem cell regulation by the Hippo pathway.
    Hiemer SE; Varelas X
    Biochim Biophys Acta; 2013 Feb; 1830(2):2323-34. PubMed ID: 22824335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TGF-β/Smads signaling pathway, Hippo-YAP/TAZ signaling pathway, and VEGF: Their mechanisms and roles in vascular remodeling related diseases.
    Liu H; Sun M; Wu N; Liu B; Liu Q; Fan X
    Immun Inflamm Dis; 2023 Nov; 11(11):e1060. PubMed ID: 38018603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease.
    Varelas X
    Development; 2014 Apr; 141(8):1614-26. PubMed ID: 24715453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of Hippo signalling by p38 signalling.
    Huang D; Li X; Sun L; Huang P; Ying H; Wang H; Wu J; Song H
    J Mol Cell Biol; 2016 Aug; 8(4):328-37. PubMed ID: 27402810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An evaluation of TAZ and YAP crosstalk with TGFβ signalling in canine osteosarcoma suggests involvement of hippo signalling in disease progression.
    Luu AK; Schott CR; Jones R; Poon AC; Golding B; Hamed R; Deheshi B; Mutsaers A; Wood GA; Viloria-Petit AM
    BMC Vet Res; 2018 Nov; 14(1):365. PubMed ID: 30477496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physiological and pathological roles of the Hippo-YAP/TAZ signaling pathway in liver formation, homeostasis, and tumorigenesis.
    Nishina H
    Cancer Sci; 2022 Jun; 113(6):1900-1908. PubMed ID: 35349740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The two sides of Hippo pathway in cancer.
    Li FL; Guan KL
    Semin Cancer Biol; 2022 Oct; 85():33-42. PubMed ID: 34265423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hippo-Yap/Taz signalling in zebrafish regeneration.
    Riley SE; Feng Y; Hansen CG
    NPJ Regen Med; 2022 Jan; 7(1):9. PubMed ID: 35087046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging role of Hippo pathway in the regulation of hematopoiesis.
    Kim I; Park T; Noh JY; Kim W
    BMB Rep; 2023 Aug; 56(8):417-425. PubMed ID: 37574808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. YAP and TAZ regulate Schwann cell proliferation and differentiation during peripheral nerve regeneration.
    Jeanette H; Marziali LN; Bhatia U; Hellman A; Herron J; Kopec AM; Feltri ML; Poitelon Y; Belin S
    Glia; 2021 Apr; 69(4):1061-1074. PubMed ID: 33336855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment.
    Johnson R; Halder G
    Nat Rev Drug Discov; 2014 Jan; 13(1):63-79. PubMed ID: 24336504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation and functions of mammalian LATS/NDR kinases: looking beyond canonical Hippo signalling.
    Hergovich A
    Cell Biosci; 2013 Aug; 3(1):32. PubMed ID: 23985307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hippo Pathway in Mammalian Adaptive Immune System.
    Yamauchi T; Moroishi T
    Cells; 2019 Apr; 8(5):. PubMed ID: 31052239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calmodulin activates the Hippo signaling pathway by promoting LATS1 kinase-mediated inhibitory phosphorylation of the transcriptional coactivator YAP.
    Thines L; Gorisse L; Li Z; Sayedyahossein S; Sacks DB
    J Biol Chem; 2022 May; 298(5):101839. PubMed ID: 35307353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. YAP/TAZ-TEAD signalling axis: A new therapeutic target in malignant pleural mesothelioma.
    Papavassiliou KA; Sofianidi AA; Papavassiliou AG
    J Cell Mol Med; 2024 Apr; 28(8):e18330. PubMed ID: 38606782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy.
    Juan WC; Hong W
    Genes (Basel); 2016 Aug; 7(9):. PubMed ID: 27589805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of Hippo signaling pathway in cancer: A MicroRNA perspective.
    Samji P; Rajendran MK; Warrier VP; Ganesh A; Devarajan K
    Cell Signal; 2021 Feb; 78():109858. PubMed ID: 33253912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.